title: Mesorhizobium peritonitis: The first reported case.
authors.affiliation: Department of Nephrology, Royal Perth Hospital, Perth, WA, Australia.
authors.forename: Anoushka
authors.initials: A
authors.lastname: Krishnan
authors.affiliation: Department of Microbiology, PathWest Laboratory Medicine, QEII Medical Centre, Perth, WA, Australia.
authors.forename: Edward
authors.initials: E
authors.lastname: Raby
authors.affiliation: Fiona Stanley Hospital, Perth, WA, Australia.
authors.forename: Harish
authors.initials: H
authors.lastname: Puttagunta
authors.affiliation: School of Pathology and Laboratory Medicine, University of Western Australia, Perth, WA, Australia.
authors.forename: Michael
authors.initials: M
authors.lastname: Leung
authors.affiliation: Department of Nephrology, Royal Perth Hospital, Perth, WA, Australia.
authors.forename: Mark
authors.initials: M
authors.lastname: Thomas
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D055499:Catheter-Related Infections / Q000175:diagnosis / Q000382:microbiology* / Q000628:therapy; D002408:Catheters, Indwelling / Q000009:adverse effects*; D020878:Device Removal; D016905:Gram-Negative Bacterial Infections / Q000175:diagnosis / Q000382:microbiology* / Q000628:therapy; D006801:Humans; D007676:Kidney Failure, Chronic / Q000175:diagnosis / Q000628:therapy*; D016030:Kidney Transplantation; D008297:Male; D059128:Mesorhizobium / Q000145:classification / Q000235:genetics / Q000302:isolation & purification*; D010530:Peritoneal Dialysis / Q000009:adverse effects* / Q000295:instrumentation; D010538:Peritonitis / Q000175:diagnosis / Q000382:microbiology* / Q000628:therapy; D021521:Ribotyping; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents
keywords: Mesorhizobium; Peritoneal dialysis; Peritonitis